肺瘤发生中的蛋白质缩:目标验证和向治疗
Yawen Zheng1,2, Hiroyuki Inuzuka3, Wenyi Wei3
1Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, China National Ministry of Education) of the Second Affiliated Hospital and Institute of Translational Medicine, Zhejiang University School of Medicine, Hangzhou 310029, China.
Fundamental research
|January 30, 2026
概括
脱,一种关键的蛋白质修饰,激活了Cullin-RING连接酶. 向缩-库林-RING链酶显示出治疗肺癌的希望,在临床试验中使用抑制剂.
科学领域:
- 生物化学 生物化学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 化是一种由E1,E2和E3酶催化的翻译后修饰.
- 化激活了库林-RING酶,这些酶通过无处不在激活来调节蛋白质降解.
- 改变的缩通路和Cullin-RING连接酶与人类癌症有关.
研究的目的:
- 审查化-库林-RING化酶在肺癌中的作用.
- 总结目前关于缩对肺癌生长,瘤发生和瘤微环境的影响的数据.
- 讨论小分子抑制剂针对肺癌治疗的缩.
主要方法:
- 文献综述化通路及其在肺癌中的作用.
- 关于化-库林-RING酶对肺癌影响的数据摘要.
- 关于小分子抑制剂的信息编制 neddylation 酶.
主要成果:
- 尼迪लेशन-Cullin-RING连接酶在肺癌中经常发生变化.
- 这些变化会影响肺癌细胞的生长,生存和瘤发生.
- 小分子缩抑制剂对肺癌细胞表现出活性.
结论:
- 向缩途径为肺癌提供了一个有前途的治疗策略.
- 需要进一步的研究和药物开发,以通过抑制缩来有效治疗肺癌.
相关概念视频
Targeted Cancer Therapies
8.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.9K
Targets for Drug Action: Overview
10.2K
Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
10.2K
Target Cell Response to Hormones
5.7K
Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
5.7K
Reliability and Validity
13.9K
Reliability and validity are two important considerations that must be made with any type of data collection. Reliability refers to the ability to consistently produce a given result. In the context of psychological research, this would mean that any instruments or tools used to collect data do so in consistent, reproducible ways.
13.9K
Lung Capacity
56.3K
The air in the lungs is measured in volumes and capacities. Lung volume measures reflect the amount of air taken in, released, or left over after a lung function, like a single inhalation. Lung capacity measures are sums of two or more lung volume measures.
56.3K
Gene Therapy
27.6K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K


